• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利冠心病患者的当前护理标准:MC'95研究。

Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.

作者信息

Magnani Bruno, Dal Palù Cesare, Zanchetti Alberto

机构信息

Institute of Cardiology, University of Bologna, Bologna, Italy.

出版信息

Ital Heart J. 2002 Feb;3(2):86-95.

PMID:11926017
Abstract

BACKGROUND

The aims of MC'95 were to verify i) whether the main risk factors for coronary heart disease had been recorded in the hospital medical records of patients admitted for coronary events; ii) how modifiable risk factors had been managed by drug therapy and lifestyle advices following hospitalization; iii) whether first-degree blood relatives of patients had been screened for coronary heart disease risk factors.

METHODS

The survey concerned 40 hospital units across Italy admitting patients with acute coronary events or offering interventional cardiology or cardiac surgery. Two thousand and four hospital records (50 for each unit) of consecutive patients (< or = 74 years, 21% women) discharged within 6 months before initiation of the study (November 1995) were reviewed and the patients were invited for a follow-up examination from 6 to 9 months after hospital discharge.

RESULTS

The prevalence of patients positive for risk factors reported was: 58.5% for high total cholesterol (> or = 5.2 mmol/l), 46.9% for high blood pressure (> or = 140/90 mmHg), 35.2% for smoking, 20.2% for high blood glucose (> 7 mmol/l), and 14.2% for obesity (body mass index > or = 30 kg/m2). A number of medical records did not provide complete information on risk factors: 24.1% for body mass index, 11.0% for serum cholesterol, and 11.6% for a family history of premature coronary heart disease. Eighty-nine percent of the patients attended the follow-up examination. Their care during the follow-up period was managed by general practitioners (30.5%), cardiologists (37.2%) and/or at hospital outpatient clinics (42.4%). At follow-up examination the prevalence of hypercholesterolemia increased to 62.2%, that of uncontrolled hypertension decreased to 32.2%, and the percentage of smokers decreased to 13.6%. The adherence to the drug treatment prescribed at discharge was as follows: 69.6% for lipid-lowering agents, 81.2% for ACE-inhibitors and beta-blockers, and 90.8% for antiplatelet agents. A family history of premature heart disease was reported in 55.1% of patients but screening for coronary heart disease risk factors was extended to relatives in less than 25% of cases.

CONCLUSIONS

The prevalence of modifiable risk factors is high in patients with different clinical manifestations of coronary heart disease. The prescriptions for secondary prevention and their efficacy after hospital discharge and the surveying of relatives for primary prevention need to be improved. For this purpose, a more coordinated intervention of primary care physicians, cardiologists and cardiac surgeons is mandatory.

摘要

背景

MC'95的目的是验证:i)冠心病的主要危险因素是否已记录在因冠心病事件入院患者的医院病历中;ii)住院后可改变的危险因素通过药物治疗和生活方式建议是如何管理的;iii)患者的一级血亲是否接受了冠心病危险因素筛查。

方法

该调查涉及意大利40个医院科室,这些科室收治急性冠脉事件患者或提供介入心脏病学或心脏外科手术。回顾了在研究开始前6个月内(1995年11月)出院的2004份连续患者(年龄≤74岁,21%为女性)的医院病历,并邀请患者在出院后6至9个月进行随访检查。

结果

报告的危险因素阳性患者患病率如下:总胆固醇高(≥5.2 mmol/L)为58.5%,高血压(≥140/90 mmHg)为46.9%,吸烟为35.2%,高血糖(>7 mmol/L)为20.2%,肥胖(体重指数≥30 kg/m²)为14.2%。一些病历未提供关于危险因素的完整信息:体重指数方面为24.1%,血清胆固醇方面为11.0%,早发冠心病家族史方面为11.6%。89%的患者参加了随访检查。随访期间他们的护理由全科医生(30.5%)、心脏病专家(37.2%)和/或医院门诊(42.4%)管理。在随访检查时,高胆固醇血症患病率增至62.2%,未控制的高血压患病率降至32.2%,吸烟者百分比降至13.6%。出院时所开药物治疗的依从性如下:降脂药为69.6%,血管紧张素转换酶抑制剂和β受体阻滞剂为81.2%,抗血小板药为90.8%。55.1%的患者报告有早发心脏病家族史,但不到25%的病例将冠心病危险因素筛查扩展至亲属。

结论

在冠心病不同临床表现的患者中,可改变危险因素的患病率很高。二级预防的处方及其出院后的疗效以及对亲属进行一级预防的筛查需要改进。为此,初级保健医生、心脏病专家和心脏外科医生进行更协调的干预是必不可少的。

相似文献

1
Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.意大利冠心病患者的当前护理标准:MC'95研究。
Ital Heart J. 2002 Feb;3(2):86-95.
2
Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.来自15个国家的冠心病患者的生活方式、危险因素管理及药物治疗的应用;欧洲心脏调查项目EUROASPIRE II的主要结果
Eur Heart J. 2001 Apr;22(7):554-72. doi: 10.1053/euhj.2001.2610.
3
Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).克罗地亚缺血性冠状动脉事件的治疗与二级预防(TASPIC-CRO研究)
Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):646-54. doi: 10.1097/01.hjr.0000183910.59741.96.
4
[Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part II. Secondary prevention of ischaemic heart disease during hospitalization].[克拉科夫缺血性心脏病二级预防项目。第二部分。住院期间缺血性心脏病的二级预防]
Przegl Lek. 2001;58(11):956-63.
5
[Effects of inpatient rehabilitation on cardiovascular risk factors in patients with coronary heart disease. PIN-Study Group].[住院康复对冠心病患者心血管危险因素的影响。PIN研究组]
Dtsch Med Wochenschr. 1999 Jul 9;124(27):817-23. doi: 10.1055/s-2007-1024425.
6
[EUROASPIRE: survey conducted by the European Society of Cardiology on secondary prevention of coronary disease. Hungarian results].[欧洲冠心病二级预防调查:欧洲心脏病学会开展的调查。匈牙利的调查结果]
Orv Hetil. 1999 Jan 31;140(5):243-8.
7
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
8
[Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].[克拉科夫缺血性心脏病二级预防项目。缺血性心脏病二级预防领域的护理质量取决于患者出院后在何处接受治疗]
Przegl Lek. 2001;58 Suppl 6:21-5.
9
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].[2000年西班牙的胆固醇血症控制。心血管疾病预防工具。卫生与消费部、西班牙心脏病学会和西班牙动脉硬化学会]
Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53.
10
Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.1997 年至 2007 年出院后期间冠心病二级预防的变化。克拉科夫缺血性心脏病二级预防计划和 EUROASPIRE II 和 III 调查的波兰部分的结果。
Kardiol Pol. 2009 Dec;67(12):1353-9.

引用本文的文献

1
Age and gender biases in secondary prevention of coronary heart disease in a Finnish university hospital setting.芬兰一家大学医院环境下冠心病二级预防中的年龄和性别偏见。
Clin Drug Investig. 2007;27(10):673-81. doi: 10.2165/00044011-200727100-00002.